ライフサイエンスコーパス: genomic medicine

1 have given great optimism for the impact of 'genomic medicine'.

2 inical use to minimize health disparities in genomic medicine.

3 ome critical to provide decision support for genomic medicine.

4 nical outcomes is a fundamental challenge in genomic medicine.

5 s made that these variants are the future of genomic medicine.

6 g, a prerequisite for physicians to practice genomic medicine.

7 inated the power of evolutionary thinking in genomic medicine.

8 mains a key challenge in systems biology and genomic medicine.

9 arch and describe the path towards an era of genomic medicine.

10 in dermatomyositis is leading down a path of genomic medicine.

11 ctive, and critical component of research in genomic medicine.

12 sive prenatal DNA testing is the vanguard of genomic medicine.

13 nd challenges and barriers to integration of genomic medicine.

14 dictive, preventive, and personalized era of genomic medicine.

15 at many feel is prerequisite to personalized genomic medicine.

16 l of which form the basis for cardiovascular genomic medicine.

17 eering to tackle challenges in molecular and genomic medicine.

18 , and industrial biotechnology as well as on genomic medicine.

19 dence-based development of best practices in genomic medicine.

20 to use targeted therapies in the context of genomic medicine, analysis of the tumor in real-time may

21 g, and Blood Institute convened a workshop, "Genomic Medicine and Lung Diseases," to discuss the pote

22 In the past decade, significant progress in genomic medicine and technologic developments has revolu

23 Such studies herald the future of genomic medicine and the opportunity for personalized pr

24 ine, consumer information needs, delivery of genomic medicine, and challenges and barriers to integra

25 of concepts such as translational medicine, genomic medicine, and personalized care, with measurable

26 he impact of FINDbase, as a key resource for Genomic Medicine applications.

27 e requested from the Texas A&M Institute for Genomic Medicine, are readily available to the scientifi

28 BD is nevertheless a challenging example for genomic medicine because the overall fraction of patient

29 brought the vision of personal genomics and genomic medicine closer to reality.

30 copy number variants (CNVs) are important in genomic medicine, CNVs have not been systematically asse

31 ed study design and 4 key areas: outcomes of genomic medicine, consumer information needs, delivery o

32 on two types of knowledge most pertinent to genomic medicine: directed genic interactions such as pa

33 To accomplish the goal of personalized genomic medicine for patients, close collaborations betw

34 e to our nascent era of personal genomes and genomic medicine has been made possible only because of

35 In recent years, genomic medicine has been moving from the bench to the b

36 Genomic medicine has entered clinical practice and the d

37 Now, genomic medicine has entered clinical practice as it per

38 Genomic medicine has now entered the clinical practice a

39 Genomic medicine holds the ultimate promise of revolutio

40 se of a large quaternary referral center for genomic medicine in the Northwest of England.

41 rating approaches for performing research in genomic medicine, including the exploration of issues re

42 led trials and 13 other studies assessed how genomic medicine is delivered and newer models of delive

43 Genomic medicine is merging with clinical practice as ou

44 However, the road to genomic medicine is paved with challenges and uncertaint

45 target the epigenome as a whole, these true 'genomic medicines' lessen the need for precision approac

46 Genomic medicine offers a growing number of methods to d

47 e background information that can be used in genomic medicine research and application studies.

48 ng the database of the Manchester Centre for Genomic Medicine, this cohort study analyzed lymphocyte

49 s of human disease, are now being applied to genomic medicine through in silico integrative genomics.

50 of ContrastRank can be an important step in genomic medicine to enable genome-based diagnosis.

51 The biggest challenge facing genomic medicine today is the development of new techniq

52 pact of ancestry-related biases in precision genomic medicine, we use 642 whole-genome sequences from

53 These challenges and opportunities for genomic medicine were central themes of the Golden Helix

54 of personalized medicine has been primarily genomic medicine, wherein it is hoped that the nucleotid

55 characteristics, most often single genes--to genomic medicine, which by its nature is comprehensive a

56 ly similar to the underpinning of predictive genomic medicine, which has the potential to shift medic

57 The next phase of genomic medicine will therefore require talented bioinfo